PTPI Stock Price | Petros Pharmaceuticals Inc P/E, Revenue, EPS, & Forecasts

Petros Pharmaceuticals Inc • PTPI

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Petros Pharmaceuticals Inc

Ticker

PTPI

Trading on

PINK

ISIN

US71678J1007

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

CEO

Headquarters

1185 Avenue of the Americas, New York, NY, United States, 10036

Employees

Website

https://petrospharma.com

Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.

Metrics

BasicAdvanced

Market cap

$1M

P/E ratio

EPS

-$60.96

Dividend Yield

0.00%

Beta

1.76

Forward P/E ratio

EBIDTA

$-7.4M

Ex dividend date

Price & volume

Market cap

$1M

Average daily volume

26.8M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

0.19

Price to book

0.45

Earnings

EPS

-$60.96

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-7.4M

Revenues (TTM)

$5.1M

Revenues per share (TTM)

$9.07

Technicals

Beta

1.76

52-week High

$16.25

52-week Low

$0.03

50-day moving average

$0.82

200-day moving average

$5.66

Short ratio

0.17

Short %

25.07%

Management effectiveness

ROE (TTM)

-2,866.76%

ROA (TTM)

-26.74%

Profit margin

-282.00%

Gross profit margin

$3.9M

Operating margin

-200.54%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

-5.90%

Share stats

Outstanding Shares

31.2M

Float

30M

Insiders %

0.51%

Institutions %

0.15%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

$1.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$9.25

-$19.25

51.95%

Q2 • 24Beat

-$13.25

-$7.25

-82.76%

Q3 • 24Missed

-$25.62

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0.7M

$-9.3M

-1,278.38%

Q4 • 24

$0M

$-2.3M

-∞%

Q1 • 25

-100.00%

-75.63%

∞%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$10.6M

$18.1M

170.21%

Q4 • 24

$17.6M

$27.2M

154.44%

Q1 • 25

65.54%

50.19%

-9.27%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$1M

$-0M

$-1.1M

$1M

Q4 • 24

$-1.5M

$8.7M

$-1.5M

Q1 • 25

-254.82%

-860.66%

-255.69%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Petros Pharmaceuticals Inc share?

Petros Pharmaceuticals Inc shares are currently traded for undefined per share.

How many shares does Petros Pharmaceuticals Inc have?

Petros Pharmaceuticals Inc currently has 31.2M shares.

Does Petros Pharmaceuticals Inc pay dividends?

No, Petros Pharmaceuticals Inc doesn't pay dividends.

What is Petros Pharmaceuticals Inc 52 week high?

Petros Pharmaceuticals Inc 52 week high is $16.25.

What is Petros Pharmaceuticals Inc 52 week low?

Petros Pharmaceuticals Inc 52 week low is $0.03.

What is the 200-day moving average of Petros Pharmaceuticals Inc?

Petros Pharmaceuticals Inc 200-day moving average is $5.66.

Who is Petros Pharmaceuticals Inc CEO?

The CEO of Petros Pharmaceuticals Inc is -.

How many employees Petros Pharmaceuticals Inc has?

Petros Pharmaceuticals Inc has 18 employees.

What is the market cap of Petros Pharmaceuticals Inc?

The market cap of Petros Pharmaceuticals Inc is $1M.

What is the P/E of Petros Pharmaceuticals Inc?

The current P/E of Petros Pharmaceuticals Inc is null.

What is the EPS of Petros Pharmaceuticals Inc?

The EPS of Petros Pharmaceuticals Inc is -$60.96.

What is the PEG Ratio of Petros Pharmaceuticals Inc?

The PEG Ratio of Petros Pharmaceuticals Inc is null.

What do analysts say about Petros Pharmaceuticals Inc?

According to the analysts Petros Pharmaceuticals Inc is considered a buy.